SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-008307
Filing Date
2017-07-31
Accepted
2017-07-31 16:41:37
Documents
66
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 715131
2 image_002.jpg GRAPHIC 6847
3 ex31-1.htm EX-31.1 17576
4 ex31-2.htm EX-31.2 17896
5 ex32-1.htm EX-32.1 5872
6 ex32-2.htm EX-32.2 5892
  Complete submission text file 0001493152-17-008307.txt   3016270

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE vbiv-20170630.xml EX-101.INS 440363
8 XBRL SCHEMA FILE vbiv-20170630.xsd EX-101.SCH 43955
9 XBRL CALCULATION FILE vbiv-20170630_cal.xml EX-101.CAL 55056
10 XBRL DEFINITION FILE vbiv-20170630_def.xml EX-101.DEF 120839
11 XBRL LABEL FILE vbiv-20170630_lab.xml EX-101.LAB 259793
12 XBRL PRESENTATION FILE vbiv-20170630_pre.xml EX-101.PRE 198879
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37769 | Film No.: 17993462
SIC: 2834 Pharmaceutical Preparations